davunetide

	davunetide
Trade Name
Orphan Indication	Progressive supranuclear palsy
USA Market Approval	USA
USA Designation Date	2009-12-07 00:00:00
Sponsor	Allon Therapeutics, Inc.;506-1168 Hamilton Street, Vancouver, BC V6B 2S2;